A case study on severe psychiatric symptoms induced by lorlatinib

Psychooncology. 2024 Jan;33(1):e6283. doi: 10.1002/pon.6283.

Authors

Michael A Liu¹, Eleanor Xu², Catherine A Shu¹

Affiliations

¹ Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.
² Department of Clinical Psychology, Columbia University, New York, New York, USA.

PMID: 38282214
PMCID: PMC10970709 (available on 2025-01-01)
DOI: 10.1002/pon.6283

No abstract available

Keywords: brain; cancer; lorlatinib; lung adenocarcinoma; oncology; psychosis.

MeSH terms

Aminopyridines / adverse effects
Humans
Lactams*
Lactams, Macrocyclic / pharmacology
Lung Neoplasms*
Pyrazoles

Substances

lorlatinib
Lactams, Macrocyclic
Lactams
Aminopyridines
Pyrazoles

Grants and funding

T32 CA203703/CA/NCI NIH HHS/United States